1. Show article details.

    Gates-backed TB drug to enter late-stage testing

    Reuters – 4:26 PM ET 04/23/2014

    The first experimental drug that fights both conventional and drug-resistant forms of tuberculosis is advancing to late-stage clinical testing, researchers said on Wednesday, raising hope for a new way to stem the growing threat of drug-resistant TB.

  2. Show article details.

    Johnson & Johnson to Host Medical Devices & Diagnostics Business Review

    PR Newswire – 2:00 PM ET 04/23/2014

    NEW BRUNSWICK, N.J., April 23, 2014Johnson & Johnson (JNJ) will host a review of its Medical Devices & Diagnostics business for the investment community beginning at 9:30 a.m. on Thursday, May 22, 2014 at the Hyatt Regency Hotel in New Brunswick, New Jersey and ending at approximately 2:30 p.m. Dominic J. Caruso, Vice President, Finance and Chief Financial Officer will host the meeting which will fea...

  3. Show article details.

    New Recycling Study Shows Lack Of Bins Is No. 1 Barrier To Recycling In The Home

    PR Newswire – 10:14 AM ET 04/17/2014

    BOSTON, April 17, 2014 Nearly three-quarters of consumers consistently recycle in the home, but despite a genuine concern for the environment, only about half do so in rooms beyond the kitchen. Absence of Bins is the Biggest Barrier to Recycling Although Americans indicate a strong willingness to recycle, good intentions aren't enough. Bins aren't the only roadblock to recycling.

  4. Show article details.

    BRIEF-UnitedHealth sees government funding cuts to private Medicare at 3 percent to 3.5 percent

    Reuters – 10:09 AM ET 04/17/2014

    UnitedHealth Group Inc (UNH) : * Says government funding cuts to private medicare are 3 percent to 3.5 percent. in 2015 * Says will work through and try to mitigate medicare cuts in 2015 * Says hepatitis c costs are a "multiple" of what it had expected for Q1 * Says hepatitis c patient volume may moderate after pent-up demand starts to. wear off * Says working with state medicaid agencies on unexpect...

  5. Show article details.

    GSK, facing bribery claims, battles to build new sales model

    Reuters – 6:39 AM ET 04/17/2014

    * Drugmaker to hire 10-20 pct more doctors in-house. * Follows move to stop paying outsiders to promote drugs. * GSK hopes for long-term competitive advantage with revamp. * Short-term challenge to maintain effective promotion. By Ben Hirschler.

  6. Show article details.

    Reckitt leans towards pharmaceuticals spin-off

    Reuters – 3:29 AM ET 04/16/2014

    * First quarter sales up 4 pct vs analyst consensus 3.7 pct. * Health unit sales up 11 pct, hygiene only 2 pct. * Pharma spin-off emerging as "strong option" By Martinne Geller.

  7. Show article details.

    Updates, advisories and surprises

    MarketWatch – 5:31 PM ET 04/15/2014

    Yahoo (YHOO) report shows Alibaba growth reaccelerated. Yahoo's (YHOO) first-quarter report shows Alibaba's regaining its growth momentum. Yahoo (YHOO) reported a 66% jump in Alibaba revenue in the Chinese Internet company's December quarter.

  8. Show article details.

    US STOCKS-Wall St ends higher as blue chips rally; Intel up late

    Reuters – 4:57 PM ET 04/15/2014

    * Coca-Cola and Johnson & Johnson (JNJ) rally after results. * Tesla and Netflix (NFLX) slide, but Twitter jumps after deal. * Intel (INTC) and Yahoo (YHOO) rise after the bell on results. * Dow up 0.6 pct; S&P 500 up 0.7 pct; Nasdaq up 0.3 pct. By Ryan Vlastelica.

  9. Show article details.

    Stocks gain for 2nd day in row after Ukraine fears ease

    MarketWatch – 4:33 PM ET 04/15/2014

    By Wallace Witkowski and Victor Reklaitis, MarketWatch. SAN FRANCISCO-- U.S. stocks closed higher Tuesday following a choppy session, bouncing back from a sizable drop that came after reports of fighting on the ground in Ukraine. The main indexes advanced for a second straight day and finished a little under their morning highs, which came as blue chips Coca-Cola Co. (KO) and Johnson& Johnson Inc. boosted sentiment with upbeat earnings reports.

  10. Show article details.

    MARKET SNAPSHOT: Stocks Gain For 2nd Day In Row After Ukraine Fears Ease

    DJ Business News – 4:33 PM ET 04/15/2014

    By Wallace Witkowski and Victor Reklaitis, MarketWatch. SAN FRANCISCO-- U.S. stocks closed higher Tuesday following a choppy session, bouncing back from a sizable drop that came after reports of fighting on the ground in Ukraine. The main indexes advanced for a second straight day and finished a little under their morning highs, which came as blue chips Coca-Cola Co. (KO) and Johnson& Johnson Inc. boosted sentiment with upbeat earnings reports.

  11. Show article details.

    US STOCKS SNAPSHOT-Wall St gets lift from Coca-Cola; Nasdaq lags

    Reuters – 4:14 PM ET 04/15/2014

    U.S. stocks ended higher after a volatile session on Tuesday, lifted by gains in Coca-Cola and Johnson & Johnson (JNJ), though weakness in Apple, Tesla and Netflix limited the Nasdaq's advance.

  12. Show article details.

    Coca-Cola up on earnings; Wynn worst S&P 500 loser

    MarketWatch – 3:48 PM ET 04/15/2014

    By Sue Chang and Saumya Vaishampayan, MarketWatch. SAN FRANCISCO-- Coca-Cola Co. (KO) gained Tuesday in the wake of its quarterly earnings while Wynn Resorts Ltd. (WYNN) was the biggest loser on the S&P 500.. The soft-drink company posted first-quarter adjusted earnings of 44 cents, in line with estimates.

  13. Show article details.

    VisionCare Appoints Industry Veterans, Mark Forchette, and John Ryan of ONSET Ventures to its Board of Directors

    PR Newswire – 2:45 PM ET 04/15/2014

    SARATOGA, Calif. Mark Forchette brings thirty years of experience in ophthalmic sales, marketing and business unit management, and has driven commercial success at three ophthalmic companies. "We are very pleased to have Mark join our Board of Directors," commented Allen W. Hill, VisionCare's President and CEO.

  14. Show article details.

    US STOCKS-Wall St falls as momentum shares sink again

    Reuters – 1:23 PM ET 04/15/2014

    * Tesla and Netflix (NFLX) slide; social media, biotech stocks drop. * Empire State manufacturing index misses forecast; CPI edges up. * Dow down 0.4 pct; S&P 500 off 0.5 pct; Nasdaq down 1.6 pct. By Chuck Mikolajczak. U.S. stocks fell on Tuesday as early gains evaporated when momentum shares once again lost ground, overshadowing a jump in Coca-Cola and Johnson & Johnson (JNJ) after their quarterly earnings.

  15. Show article details.

    Sales of Johnson's New Hepatitis Drug Soars

    DJ Business News – 1:15 PM ET 04/15/2014

    Sales of Johnson& Johnson's new hepatitis C drug soared during its first full quarter on the market, in another sign of strong demand--and high prices--for a new generation of treatments for the liver-damaging illness. The higher-than-expected $354 million in first-quarter sales for J&J's Olysio follows evidence that another new hepatitis C drug, Gilead Sciences Inc.' s Sovaldi, is having one of the best-selling new drug launches in history. Gilead is schedule to release...

  16. Show article details.

    Sales of Johnson & Johnson's New Hepatitis Drug Soars

    DJ Business News – 12:55 PM ET 04/15/2014

    Sales of Johnson& Johnson's new hepatitis C drug soared during its first full quarter on the market, in another sign of strong demand--and high prices--for a new generation of treatments for the liver-damaging illness. The higher-than-expected $354 million in first-quarter sales for J&J's Olysio follows evidence that another new hepatitis C drug, Gilead Sciences Inc.' s Sovaldi, is having one of the best-selling new drug launches in history. Gilead is schedule to release...

  17. Show article details.

    US STOCKS-Wall St dips as data, sinking momentum shares offset earnings

    Reuters – 11:07 AM ET 04/15/2014

    * CPI edges higher, Empire State manufacturing misses expectations. * Materials under pressure after Chile cuts copper outlook. * Indexes: Dow up 0.08 pct, S&P up 0.11 pct, Nasdaq off 0.39 pct. By Chuck Mikolajczak. U.S. stocks dipped on Tuesday, as gains in Coca Cola and Johnson & Johnson (JNJ) after their quarterly earnings were offset by mixed economic data and a resumed slide in momentum shares.

  18. Coke, J&J lead Dow gainers after strong earnings

    MarketWatch – 9:33 AM ET 04/15/2014
  19. Show article details.

    Stock futures up as Coke, J&J rise after earnings

    MarketWatch – 9:09 AM ET 04/15/2014

    By Sara Sjolin and Victor Reklaitis, MarketWatch. NEW YORK-- U.S. stock futures pointed to a higher open for Wall Street on Tuesday, helped by earnings- driven gains for blue chips Coca-Cola Co. (KO) and Johnson& Johnson. Tuesday could be an eventful trading day, with investors assessing a larger-than-expected rise in consumer prices, reports of excess credit in China that weighed on stocks there and several Federal Reserve speeches.

  20. Show article details.

    US STOCKS-Wall St to edge higher after earnings, data

    Reuters – 9:07 AM ET 04/15/2014

    * CPI edges higher, Empire State manufacturing misses expectations. * Yahoo (YHOO), Morgan Stanley rise after analyst upgrades. * Futures up: Dow 22 pts, S&P 2.75 pts, Nasdaq 6.75 pts. By Chuck Mikolajczak. U.S. stock index futures pointed to a modestly higher open on Tuesday as earnings from Coca Cola and Johnson & Johnson (JNJ) helped overshadow a mixed bag of economic data.

Page:

Today's and Upcoming Events

  • Apr
    24

    Shareholders Meeting

  • May
    22

    Johnson and Johnson Medical Devices and Diagnostics Business Review
    5/22/2014 to 5/22/2014 , , Listen

  • Jul
    15

    JNJ to announce Q2 earnings Before Market (Unconfirmed)

Past Events (last 90 days)

  • Apr
    15

    JNJ Earnings Conference Call at 8:30 AM Listen

  • Feb
    21

    JNJ ex-Dividend for $0.66 on 2/21/2014

    • Announce Date: 1/2/2014
    • Record Date: 2/25/2014
    • Pay Date: 3/11/2014
Data provided by Wall Street Horizon, Inc. © 2014

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.